Filing Details
- Accession Number:
- 0001562180-17-003887
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-14 18:51:20
- Reporting Period:
- 2017-12-14
- Accepted Time:
- 2017-12-14 18:51:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1597553 | Sage Therapeutics Inc. | SAGE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1612861 | Albert Robichaud | C/O Sage Therapeutics, Inc. 215 First Street Cambridge MA 02142 | Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-12-14 | 1,500 | $156.31 | 152,759 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-12-14 | 3,700 | $157.27 | 149,059 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-12-14 | 16,748 | $158.18 | 132,311 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-12-14 | 8,734 | $159.46 | 123,577 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-12-14 | 21,410 | $160.12 | 102,167 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-12-14 | 6,187 | $161.40 | 95,980 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-12-14 | 700 | $162.21 | 95,280 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-12-14 | 1,021 | $163.93 | 94,259 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- This transaction was executed in multiple trades at prices ranging from $155.81 USD to $156.72 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $156.82 USD to $157.80 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $157.83 USD to $158.81 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $158.90 USD to $159.8901 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $159.90 USD to $160.89 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $162.01 USD to $162.45 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $163.57 USD to $164.24 USD. The price reported above reflects the weighted average sale price.